Modulation of Lactobacillus casei in ileal and fecal samples from healthy volunteers after consumption of a fermented milk containing Lactobacillus casei DN-114 001Rif

Canadian Journal of Microbiology

Volumn 54, Issue 8, 2008, Pages 660-667

  Rochet, Violaine ^a   Rigottier Gois, Lionel ^a   Levenez, Florence ^a   Cadiou, Julie ^a   Marteau, Philippe ^b   Bresson, Jean Louis ^c   Goupil Feillerat, Nathalie ^d   Doré, Joël ^a  

^a CEMAGREF   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d DANONE RESEARCH   (France)

Author keywords

Digestive tract; Human microbiota; Lactobacillus casei; Probiotic; Recovery

Indexed keywords

FOOD ADDITIVES;

DIGESTIVE TRACT; FECAL SAMPLES; FERMENTED MILKS; HUMAN MICROBIOTA; IMMUNE SYSTEMS; LACTOBACILLUS CASEI; LACTOBACILLUS CASEI DN-114 001; PROBIOTIC; PROBIOTIC STRAINS; RECOVERY;

MODULATION;

DNA; PROBIOTIC AGENT;

BACTERIUM; DIGESTIVE SYSTEM; FECES; FERMENTATION; IMMUNE SYSTEM; MILK; PROBIOTICS;

ADULT; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FECES ANALYSIS; FERMENTED PRODUCT; FLUID INTAKE; FLUORESCENCE IN SITU HYBRIDIZATION; GEL ELECTROPHORESIS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; ILEUM MUCOSA; INGESTION; LACTOBACILLUS CASEI; MILK; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TEMPERATURE SENSITIVITY;

ADULT; CULTURED MILK PRODUCTS; DNA, BACTERIAL; FECES; FEMALE; FOOD MICROBIOLOGY; HUMANS; ILEUM; LACTOBACILLUS CASEI; MALE; POLYMERASE CHAIN REACTION; PROBIOTICS;

LACTOBACILLUS CASEI;

EID: 49449085434     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W08-050     Document Type: Article

References (36)

1. Alander, M., Satokari, R., Korpela, R., Saxelin, M., Vilpponen-Salmela, T., Mattila-Sandholm, T., and von Wright, A. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65: 351-354. PMID:9872808.
2. Amann, R.I., Binder, B.J., Olson, R.J., Chisholm, S.W., Devereux, R., and Stahl, D.A. 1990. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl. Environ. Microbiol. 56: 1919-1925.
3. Borruel, N., Carol, M., Casellas, F., Antolin, M., de Lara, F., Espin, E., et al. 2002. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut, 51: 659-664. doi:10.1136/gut.51.5.659. PMID:12377803.
4. Collins, J.K., Dunne, C., Murphy, L., Morrissey, D., O'Mahony, L., O'Sullivan, E., et al. 2002. A randomised controlled trial of a probiotic Lactobacillus strain in healthy adults: assessment of its delivery, transit and influence on microbial flora and enteric immunity. Microb. Ecol. Health Dis. 14: 81-89. doi:10.1080/08910600260081720.
5. de Man, J.C., Rogosa, M., and Sharpe, M.E. 1960. A medium for the cultivation of lactobacilli. J. Appl. Microbiol. 23: 130-135. doi:10.1111/j.1365-2672.1960.tb00188.x.
6. Drouault, S., and Corthier, G. 2001. Health effects of lactic acid bacteria ingested in fermented milk. Vet. Res. 32: 101-117. doi:10.1051/vetres:2001115. PMID:11368077.
7. Franks, A.H., Harmsen, H.J., Raangs, G.C., Jansen, G.J., Schut, F., and Welling, G.W. 1998. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 64: 3336-3345.
8. Freitas, M., Tavan, E., Cayuela, C., Diop, L., Sapin, C., and Trugnan, G. 2003. Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol. Cell, 95: 503-506. doi:10.1016/j.biolcel.2003.08.004. PMID:14630386.
9. Fujiwara, S., Seto, Y., Kimura, A., and Hashiba, H. 2001. Intestinal transit of an orally administered streptomycin-rifampicin-resistant variant of Bifidobacterium longum SBT2928: its long-term survival and effect on the intestinal microflora and metabolism. J. Appl. Microbiol. 90: 43-52. doi:10.1046/j.1365-2672.2001.01205.x. PMID:11155121.
10. Fuller, R. 1989. Probiotics in man and animals. J. Appl. Bacteriol. 66: 365-378. PMID:2666378.
11. Godon, J.J., Zumstein, E., Dabert, P., Habouzit, F., and Moletta, R. 1997. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl. Environ. Microbiol. 63: 2802-2813. PMID:9212428.
12. Goldin, B.R., Gorbach, S.L., Saxelin, M., Barakat, S., Gualtieri, L., and Salminen, S. 1992. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37: 121-128. doi:10.1007/BF01308354. PMID:1728516.
13. Harmsen, H.J., Elfferich, P, Schut, F., and Welling, G.W. 1999. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb. Ecol. Health, 11: 3-12.
14. Harmsen, H.J., Gibson, G.R., Elfferich, P., Raangs, G.C., Wildeboer-Veloo, A.C., Argaiz, A., et al. 2000. Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol. Lett. 183: 125-129.
15. Langendijk, P.S., Schut, F., Jansen, G.J., Raangs, G.C., Kamphuis, G.R., Wilkinson, M.H., et al. 1995. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl. Environ. Microbiol. 61: 3069-3079.
16. Lay, C., Rigottier-Gois, L., Holmstrom, K., Rajilic, M., Vaughan, E.E., de Vos, W.M., et al. 2005. Colonic microbiota signatures across five northern European countries. Appl. Environ. Microbiol. 71: 4153-4155. doi:10.1128/AEM.71.7.4153-4155. 2005. PMID:16000838.
17. Lederberg, J. 1989. Replica plating and indirect selection of bacterial mutants: isolation of preadaptive mutants in bacteria by sib selection. Genetics, 121: 395-399. PMID:2653959.
18. Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., and Scheifer, K.H. 1996. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology, 142: 1097-1106. PMID:15748992.
19. Marteau, P.R., de Vrese, M., Cellier, C.J., and Schrezenmeir, J. 2001. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 73: 430S-436S. PMID:11157353.
20. Marzotto, M., Maffeis, C., Paternoster, T., Ferrario, R., Rizzotti, L., Pellegrino, M., et al. 2006. Lactobacillus paracasei A survives gastrointestinal passage and affects the fecal microbiota of healthy infants. Res. Microbiol. 157: 857-866. doi:10.1016/j.resmic.2006.06.007. PMID:16934438.
21. Oozeer, R., Goupil-Feuillerat, N., Alpert, C.A., van de Guchte, M., Anba, J., Mengaud, J., and Corthier, G. 2002. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl. Environ. Microbiol. 68: 3570-3574. doi:10.1128/AEM.68.7.3570-3574.2002. PMID:12089044.
22. Oozeer, R., Mater, D.D.G., Goupil-Feuillerat, N., and Corthier, G. 2004. Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota. Appl. Environ. Microbiol. 70: 6992-6997. doi:10.1128/AEM.70.12.6992-6997.2004. PMID:15574892.
23. Oozeer, R., Leplingard, A., Mater, D.D.G., Mogenet, A., Michelin, R., Seksek, I., et al. 2006. Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl. Environ. Microbiol. 72: 5615-5617. doi:10.1128/AEM.00722-06. PMID:16885316.
24. Parassol, N., Freitas, M., Thoreux, K., Dalmasso, G., Bourdet-Sicard, R., and Rampal, P. 2005. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res. Microbiol. 156: 256-262. PMID:15748992.
25. Pedone, C.A., Bernabeu, A.O., Postaire, E.R., Bouley, C.F., and Reinert, P. 1999. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int. J. Clin. Pract. 53: 179-184. PMID:10665128.
26. Pedone, C.A., Arnaud, C.C., Postaire, E.R., Bouley, C.F., and Reinert, P. 2000. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int. J. Clin. Pract. 54: 568-571. PMID:11220983.
27. Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., et al. 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology, 126: 520-528. doi:10.1053/j.gastro.2003.11.019. PMID:14762789.
28. Rigottier-Gois, L., Le Bourhis, A.-G., Gramet, G., Rochet, V., and Dore, J. 2003. Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol. Ecol. 43: 237-245. doi:10.1111/j.1574-6941.2003.tb01063.x.
29. Rochet, V., Rigottier-Gois, L., Rabot, S., and Dore, J. 2004. Validation of fluorescent in situ hybridization combined with flow cytometry for assessing interindividual variation in the composition of human fecal microflora during long-term storage of samples. J. Microbiol. Methods, 59: 263-270. doi:10.1016/j.mimet.2004.07.012. PMID:15369862.
30. Rochet, V., Rigottier-Gois, L., Sutren, M., Krementscki, M.N., Andrieux, C., Furet, J.P., et al. 2006. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br. J. Nutr. 95: 421-429. doi:10.1079/BJN20051625. PMID:16469162.
31. Rochet, V., Rigottier-Gois, L., Ledaire, A., Andrieux, C., Sutren, M., Rabot, S., et al. 2008. Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults. J. Mol. Microbiol. Biotechnol. 14: 128-136. doi:10.1159/000106092. PMID:17957120.
32. Sghir, A., Gramet, G., Suau, A., Rochet, V., Pochart, P., and Dore, J. 2000. Quantification of bacterial groups with human fecal flora by oligonucleotide probe hybridization. Appl. Environ. Microbiol. 66: 2263-2266. PMID:15748992.
33. Tannock, G.W. 2002. Analysis of the intestinal microflora using molecular methods. Eur. J. Clin. Nutr. 56(Suppl. 4): S44-S49. doi:10.1038/sj.ejcn. 1601661. PMID:12556947.
34. Teitelbaum, J.E., and Walker, W.A. 2002. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu. Rev. Nutr. 22: 107-138. doi:10.1146/annurev.nutr.22.110901.145412. PMID:12055340.
35. Tuohy, K.M., Pinart-Gilberga, M., Jones, M., Hoyles, L., McCartney, A.L., and Gibson, G.R. 2006. Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J. Appl. Microbiol. 102: 1026-1032. doi:10.1111/j.1365-2672.2006.03154.x.
36. Wallner, G., Amann, R., and Beisker, W. 1993. Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry, 14: 136-143. doi:10.1002/cyto.990140205. PMID:7679962.